Article Information
History
- January 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hassen Kared1,2,†,
- Asia-Sophia Wolf3,
- Amin Alirezaylavasani1,
- Anthony Ravussin3,
- Guri Solum3,
- Trung The Tran2,4,
- Fridtjof Lund-Johansen2,4,
- John Torgils Vaage2,
- Lise Sofie Nissen-Meyer2,
- Unni C. Nygaard3,
- Olav Hungnes3,
- Anna H Robertson3,
- Lisbeth Meyer Næss3,
- Lill Trogstad3,
- Per Magnus5,
- Ludvig A Munthe1,2,*,† and
- Siri Mjaaland3,*
- 1KG Jebsen Centre for B cell malignancy, Institute of Clinical medicine, University of Oslo
- 2Department of Immunology, Oslo University Hospital, Oslo, Norway
- 3Division of Infection Control, Norwegian Institute of Public Health, Oslo
- 4ImmunoLingo Convergence Center, Institute of Clinical medicine, University of Oslo, Oslo, Norway
- 5Center for Fertility and Health, Norwegian Institute of Public Health, Oslo
- ↵†Corresponding authors: Hassen Kared, e-mail: hassen.kared{at}medisin.uio.no, Ludvig A Munthe, e-mail: l.a.munthe{at}medisin.uio.no
↵* These authors contributed equally to this work
Posted January 13, 2022.
